Cargando…

Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype

BACKGROUND: The irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose pathogenesis is not completely understood. Its high prevalence and the considerable effects on quality of life make IBS a disease with high social cost. Recent studies suggest that low grade mucosal immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Belmonte, Liliana, Beutheu Youmba, Stéphanie, Bertiaux-Vandaële, Nathalie, Antonietti, Michel, Lecleire, Stéphane, Zalar, Alberto, Gourcerol, Guillaume, Leroi, Anne-Marie, Déchelotte, Pierre, Coëffier, Moïse, Ducrotté, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461726/
https://www.ncbi.nlm.nih.gov/pubmed/23028414
http://dx.doi.org/10.1371/journal.pone.0042777
_version_ 1782245115402649600
author Belmonte, Liliana
Beutheu Youmba, Stéphanie
Bertiaux-Vandaële, Nathalie
Antonietti, Michel
Lecleire, Stéphane
Zalar, Alberto
Gourcerol, Guillaume
Leroi, Anne-Marie
Déchelotte, Pierre
Coëffier, Moïse
Ducrotté, Philippe
author_facet Belmonte, Liliana
Beutheu Youmba, Stéphanie
Bertiaux-Vandaële, Nathalie
Antonietti, Michel
Lecleire, Stéphane
Zalar, Alberto
Gourcerol, Guillaume
Leroi, Anne-Marie
Déchelotte, Pierre
Coëffier, Moïse
Ducrotté, Philippe
author_sort Belmonte, Liliana
collection PubMed
description BACKGROUND: The irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose pathogenesis is not completely understood. Its high prevalence and the considerable effects on quality of life make IBS a disease with high social cost. Recent studies suggest that low grade mucosal immune activation, increased intestinal permeability and the altered host-microbiota interactions that modulate innate immune response, contribute to the pathophysiology of IBS. However, the understanding of the precise molecular pathophysiology remains largely unknown. METHODOLOGY AND FINDINGS: In this study our objective was to evaluate the TLR expression as a key player in the innate immune response, in the colonic mucosa of IBS patients classified into the three main subtypes (with constipation, with diarrhea or mixed). TLR2 and TLR4 mRNA expression was assessed by real time RT-PCR while TLRs protein expression in intestinal epithelial cells was specifically assessed by flow cytometry and immunofluorescence. Mucosal inflammatory cytokine production was investigated by the multiplex technology. Here we report that the IBS-Mixed subgroup displayed a significant up-regulation of TLR2 and TLR4 in the colonic mucosa. Furthermore, these expressions were localized in the epithelial cells, opening new perspectives for a potential role of epithelial cells in host-immune interactions in IBS. In addition, the increased TLR expression in IBS-M patients elicited intracellular signaling pathways resulting in increased expression of the mucosal proinflammatory cytokines IL-8 and IL1β. CONCLUSIONS: Our results provide the first evidence of differential expression of TLR in IBS patients according to the disease subtype. These results offer further support that microflora plays a central role in the complex pathophysiology of IBS providing novel pharmacological targets for this chronic gastrointestinal disorder according to bowel habits.
format Online
Article
Text
id pubmed-3461726
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34617262012-10-01 Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype Belmonte, Liliana Beutheu Youmba, Stéphanie Bertiaux-Vandaële, Nathalie Antonietti, Michel Lecleire, Stéphane Zalar, Alberto Gourcerol, Guillaume Leroi, Anne-Marie Déchelotte, Pierre Coëffier, Moïse Ducrotté, Philippe PLoS One Research Article BACKGROUND: The irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose pathogenesis is not completely understood. Its high prevalence and the considerable effects on quality of life make IBS a disease with high social cost. Recent studies suggest that low grade mucosal immune activation, increased intestinal permeability and the altered host-microbiota interactions that modulate innate immune response, contribute to the pathophysiology of IBS. However, the understanding of the precise molecular pathophysiology remains largely unknown. METHODOLOGY AND FINDINGS: In this study our objective was to evaluate the TLR expression as a key player in the innate immune response, in the colonic mucosa of IBS patients classified into the three main subtypes (with constipation, with diarrhea or mixed). TLR2 and TLR4 mRNA expression was assessed by real time RT-PCR while TLRs protein expression in intestinal epithelial cells was specifically assessed by flow cytometry and immunofluorescence. Mucosal inflammatory cytokine production was investigated by the multiplex technology. Here we report that the IBS-Mixed subgroup displayed a significant up-regulation of TLR2 and TLR4 in the colonic mucosa. Furthermore, these expressions were localized in the epithelial cells, opening new perspectives for a potential role of epithelial cells in host-immune interactions in IBS. In addition, the increased TLR expression in IBS-M patients elicited intracellular signaling pathways resulting in increased expression of the mucosal proinflammatory cytokines IL-8 and IL1β. CONCLUSIONS: Our results provide the first evidence of differential expression of TLR in IBS patients according to the disease subtype. These results offer further support that microflora plays a central role in the complex pathophysiology of IBS providing novel pharmacological targets for this chronic gastrointestinal disorder according to bowel habits. Public Library of Science 2012-08-17 /pmc/articles/PMC3461726/ /pubmed/23028414 http://dx.doi.org/10.1371/journal.pone.0042777 Text en © 2012 Belmonte et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Belmonte, Liliana
Beutheu Youmba, Stéphanie
Bertiaux-Vandaële, Nathalie
Antonietti, Michel
Lecleire, Stéphane
Zalar, Alberto
Gourcerol, Guillaume
Leroi, Anne-Marie
Déchelotte, Pierre
Coëffier, Moïse
Ducrotté, Philippe
Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype
title Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype
title_full Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype
title_fullStr Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype
title_full_unstemmed Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype
title_short Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype
title_sort role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461726/
https://www.ncbi.nlm.nih.gov/pubmed/23028414
http://dx.doi.org/10.1371/journal.pone.0042777
work_keys_str_mv AT belmonteliliana roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT beutheuyoumbastephanie roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT bertiauxvandaelenathalie roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT antoniettimichel roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT lecleirestephane roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT zalaralberto roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT gourcerolguillaume roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT leroiannemarie roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT dechelottepierre roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT coeffiermoise roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype
AT ducrottephilippe roleoftolllikereceptorsinirritablebowelsyndromedifferentialmucosalimmuneactivationaccordingtothediseasesubtype